Insider Selling: Cibus, Inc. (NASDAQ:CBUS) Director Sells 2,300 Shares of Stock

Cibus, Inc. (NASDAQ:CBUS) Director Gerhard Prante sold 2,300 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $4.46, for a total value of $10,258.00. Following the transaction, the director now owns 66,357 shares of the company’s stock, valued at approximately $295,952.22. The trade was a 3.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Gerhard Prante also recently made the following trade(s):

• On Wednesday, November 27th, Gerhard Prante sold 1,150 shares of Cibus stock. The shares were sold at an average price of $4.50, for a total value of $5,175.00.
• On Monday, November 18th, Gerhard Prante sold 1,150 shares of Cibus stock. The shares were sold at an average price of $4.53, for a total value of $5,209.50.

Cibus Trading Down 7.0 %

Shares of Cibus stock traded down $0.33 during trading hours on Tuesday, reaching $4.39. The stock had a trading volume of 150,584 shares, compared to its average volume of 135,486. Cibus, Inc. has a twelve month low of $2.86 and a twelve month high of $23.18. The firm has a market capitalization of $116.16 million, a PE ratio of -0.20 and a beta of 1.86. The stock’s 50 day moving average is $4.00 and its 200 day moving average is $7.30.

Institutional Investors Weigh In On Cibus

A number of institutional investors have recently made changes to their positions in CBUS. SG Americas Securities LLC acquired a new position in shares of Cibus during the third quarter worth about $33,000. Virtu Financial LLC acquired a new position in Cibus in the 3rd quarter valued at about $48,000. HighTower Advisors LLC lifted its position in Cibus by 20.6% in the third quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock valued at $52,000 after purchasing an additional 2,750 shares during the period. Barclays PLC grew its stake in shares of Cibus by 287.2% during the 3rd quarter. Barclays PLC now owns 20,269 shares of the company’s stock worth $66,000 after purchasing an additional 15,034 shares during the period. Finally, Wellington Management Group LLP acquired a new stake in Cibus in the third quarter valued at $111,000. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently commented on CBUS. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $20.00 price target on shares of Cibus in a research note on Tuesday, October 22nd. Alliance Global Partners reduced their price target on shares of Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a research report on Tuesday, September 24th. Finally, HC Wainwright restated a “buy” rating and issued a $25.00 price target on shares of Cibus in a research note on Monday, November 11th.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.